@article {1783,
	title = {Iatrogenic Creutzfeldt-Jakob disease subsequent to dural graft: persisting risk after 1987.},
	volume = {10},
	year = {2003},
	note = {Status: MEDLINE; Publishing Model: Journal available in: Print Citation processed from: Print; NLM Journal Code: daf, 9506311},
	month = {Sep},
	pages = {1},
	address = {England},
	abstract = {The first case of Creutzfeldt-Jakob disease (CJD) related to the use of a dura mater graft of cadaveric origin was identified in 1987 and this procedure is now considered as one of the main causes of iatrogenic CJD. Although the decontamination procedure for the preparation of graft material was modified, the product was withdrawn from the market in many countries a few years later and replaced by synthetic material. In this context, two patients treated in our institution developed CJD following a cadaveric dural graft performed after cerebral and lumbar trauma. Their clinical presentation, showing predominant cerebellar symptoms, late deterioration and myoclonic jerks, and a rapid disease course until death, was similar to that of previously reported cases involving the iatrogenic form. As the graft for one of the patients was performed in 1991 (several years after modification of the decontamination procedure), this fourth reported case suggests that the risk of iatrogenic CJD may have persisted in some patients treated after 1987, when grafts of cadaveric origin were totally abandoned.},
	keywords = {Adult, Brain Tissue Transplantation / ae [Adverse Effects], Creutzfeldt-Jakob Syndrome / di [Diagnosis], Creutzfeldt-Jakob Syndrome / et [Etiology], Dura Mater / tr [Transplantation], Humans, Iatrogenic Disease / ep [Epidemiology], IM, Male, Middle Aged, Risk Factors},
	issn = {1351-5101; 1351-5101},
	author = {Boutoleau,C. and Guillon,B. and Martinez,F. and Vercelletto,M. and Faure,A. and Feve,J. R.}
}
